A review of neuroimaging biomarkers of Alzheimer’s disease
- Author:
Tinu Varghese
;
R Sheelakumari
;
Jija S James
;
PS Mathuranath
- Publication Type:Journal Article
- From:Neurology Asia
2013;18(3):239-248
- CountryMalaysia
- Language:English
-
Abstract:
Neuroimaging biomarkers have potential role in the early diagnosis as well as periodic follow-up of
neurodegenerative diseases such as Alzheimer’s disease (AD). Structural imaging biomarkers can be
used to predict those who are at risk or in preclinical stages of AD. It could possibly be useful even
in predicting the conversion of Mild Cognitive Impairment (MCI) an early stage of AD to AD. In
addition there has been a lot of progress in molecular imaging in AD. This article presents a review
of recent progress in selected imaging biomarkers for early diagnosis, classification, and progression,
of AD. A comprehensive integrative strategy initiated early in the cognitive decline is perhaps the
most effective method of controlling progression to Alzheimer’s disease.
- Full text:P020150706540855018953.pdf
